ATE304014T1 - Neue kristalline form eines pyrrolidylthiocarbapenem-derivates - Google Patents

Neue kristalline form eines pyrrolidylthiocarbapenem-derivates

Info

Publication number
ATE304014T1
ATE304014T1 AT01917764T AT01917764T ATE304014T1 AT E304014 T1 ATE304014 T1 AT E304014T1 AT 01917764 T AT01917764 T AT 01917764T AT 01917764 T AT01917764 T AT 01917764T AT E304014 T1 ATE304014 T1 AT E304014T1
Authority
AT
Austria
Prior art keywords
crystalline form
new crystalline
pyrrolidylthiocarbapenem derivative
pyrrolidylthiocarbapenem
derivative
Prior art date
Application number
AT01917764T
Other languages
German (de)
English (en)
Inventor
Izumi Saitoh
Masayuki Takahira
Toshio Kawakita
Yasuyuki Yoshioka
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18614158&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE304014(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of ATE304014T1 publication Critical patent/ATE304014T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
AT01917764T 2000-03-31 2001-03-30 Neue kristalline form eines pyrrolidylthiocarbapenem-derivates ATE304014T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000099868 2000-03-31
PCT/JP2001/002834 WO2001072750A1 (fr) 2000-03-31 2001-03-30 Nouvelle forme cristalline d'un derive de pyrrolidylthiocarbapenem

Publications (1)

Publication Number Publication Date
ATE304014T1 true ATE304014T1 (de) 2005-09-15

Family

ID=18614158

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01917764T ATE304014T1 (de) 2000-03-31 2001-03-30 Neue kristalline form eines pyrrolidylthiocarbapenem-derivates

Country Status (17)

Country Link
US (5) US20030153191A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP1270575B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP3375084B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100472842B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1192030C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE304014T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (2) AU2001244692B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BRPI0109712B8 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2404703C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (2) CY1105674T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE60113243T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK1270575T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2252205T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MXPA02009592A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TWI293631B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2001072750A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA200207675B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001244692B2 (en) * 2000-03-31 2004-10-14 Shionogi & Co., Ltd. Novel crystal form of pyrrolidylthiocarbapenem derivative
JP5004355B2 (ja) * 2001-05-10 2012-08-22 塩野義製薬株式会社 アセチルチオピロリジン誘導体の製法
JP2005509037A (ja) * 2001-11-16 2005-04-07 ランバクシー ラボラトリーズ リミテッド 結晶イミペネム製造方法
TWI353855B (en) * 2005-05-26 2011-12-11 Shionogi & Co Method for preparing an aqueous solution of doripe
KR20090007572A (ko) * 2006-04-28 2009-01-19 카네카 코포레이션 카르바페넴 항생 물질 중간체의 개량된 정석 방법
WO2008006298A1 (fr) * 2006-07-03 2008-01-17 Chengdu Di'ao Jiuhong Pharmaceutical Factory Nouvelle forme cristalline de doripenem, préparation, procédé et utilisations de celle-ci
CN101191787B (zh) * 2006-11-21 2011-07-27 上海医药工业研究院 高效液相色谱法测定多利培南含量的方法
EP2276762B1 (en) 2008-03-24 2014-10-01 Ranbaxy Laboratories Limited Process for the preparation of sterile doripenem
WO2011150679A1 (zh) * 2010-06-03 2011-12-08 山东轩竹医药科技有限公司 碳青霉烯类衍生物或其水合物的晶型及其制备方法与用途
CN102977101A (zh) * 2011-09-07 2013-03-20 中国人民解放军军事医学科学院毒物药物研究所 多尼培南一水合物、其药物组合物、其制备方法和用途
CN102285988B (zh) * 2011-09-08 2012-09-05 上海希迈医药科技有限公司 一种多尼培南水合物晶体及其制备方法
EP2776440A1 (en) * 2011-11-08 2014-09-17 Ranbaxy Laboratories Limited Process for the preparation of polymorphs of doripenem
CN104072497B (zh) * 2013-03-29 2017-10-03 石药集团中奇制药技术(石家庄)有限公司 一种多尼培南新结晶及其制备方法
CN103389347B (zh) * 2013-07-26 2015-12-09 深圳市海滨制药有限公司 高效液相色谱法测定多尼培南的方法
CN106255694A (zh) * 2014-04-28 2016-12-21 Jw制药公司 新型多尼培南晶体及其制备方法
KR20160007679A (ko) 2016-01-04 2016-01-20 제일약품주식회사 도리페넴의 신규한 결정형

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5317016A (en) * 1991-08-20 1994-05-31 Shionogi Seiyaku Kabushiki Kaisha Pyrrolidylthiocarbapenem derivative
US5539102A (en) * 1992-02-21 1996-07-23 Shionogi Seiyaku Kabushiki Kaisha Production method for sulfamide
ATE223916T1 (de) * 1994-05-02 2002-09-15 Shionogi & Co Kristalline pyrrolidylthiocarbapenem derivate, lyophilisierste präparationen dieser kristalle und verfahren zu deren herstellung
JP3558684B2 (ja) * 1994-06-28 2004-08-25 塩野義製薬株式会社 ピロリジルチオカルバペネム誘導体の乾燥方法
AU2001244692B2 (en) * 2000-03-31 2004-10-14 Shionogi & Co., Ltd. Novel crystal form of pyrrolidylthiocarbapenem derivative
KR101089529B1 (ko) * 2003-02-14 2011-12-05 시오노기세이야쿠가부시키가이샤 카르바페넴 중간체의 결정
US20120035357A1 (en) 2009-02-26 2012-02-09 Orchid Chemicals & Pharmaceuticals Ltd. Process for the preparation of carbapenem antibiotic

Also Published As

Publication number Publication date
ZA200207675B (en) 2003-09-25
US20130059831A1 (en) 2013-03-07
US20150031664A1 (en) 2015-01-29
AU4469201A (en) 2001-10-08
DK1270575T3 (da) 2006-01-16
BRPI0109712B8 (pt) 2021-05-25
CN1432016A (zh) 2003-07-23
WO2001072750A1 (fr) 2001-10-04
TWI293631B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2008-02-21
DE60113243T2 (de) 2006-02-16
CN1192030C (zh) 2005-03-09
US9221823B2 (en) 2015-12-29
US8247402B2 (en) 2012-08-21
US20070060562A1 (en) 2007-03-15
BR0109712A (pt) 2003-04-29
US20080207586A1 (en) 2008-08-28
KR20020087446A (ko) 2002-11-22
CY2009001I1 (el) 2009-11-04
EP1270575A1 (en) 2003-01-02
KR100472842B1 (ko) 2005-03-10
CY1105674T1 (el) 2010-07-28
US20030153191A1 (en) 2003-08-14
JP3375084B2 (ja) 2003-02-10
CA2404703A1 (en) 2002-09-26
ES2252205T3 (es) 2006-05-16
EP1270575B1 (en) 2005-09-07
CA2404703C (en) 2007-06-05
MXPA02009592A (es) 2003-03-12
DE60113243D1 (de) 2005-10-13
AU2001244692B2 (en) 2004-10-14
BRPI0109712B1 (pt) 2017-10-24
EP1270575A4 (en) 2004-02-18
CY2009001I2 (el) 2009-11-04

Similar Documents

Publication Publication Date Title
ATE304014T1 (de) Neue kristalline form eines pyrrolidylthiocarbapenem-derivates
IL157773A0 (en) 2-amino-propanol derivatives
HUP0003230A2 (hu) Egy N-fenil-(2-piridil)-amin-származék kristálymódosulata, valamint előállítási eljárásai és alkalmazása
CA2442219A1 (en) Enantioselective synthesis of azetidinone intermediate compounds
HU9400578D0 (en) Oxazolidinedion derivatives, their production and use
CA2429590A1 (en) Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
CA2150123A1 (en) Aminomethylene substituted non-aromatic heterocycles
CA2328780A1 (en) Dihydropyrimidines
BR0214031A (pt) Compostos de heteroarila azabicìclico substituìdos para o tratamento de doenças
BE2013C004I2 (en) Phosphonocephem derivatives, process for the preparation of the same, and use thereof
CA2043709A1 (en) Antimigraine alkoxypyrimidine derivatives
ATE238298T1 (de) Tetraderivate, ihre herstellung und verwendung
PL308545A1 (en) Novel substituted azethydinones as anti-inflammatory and anti-degenerative agents
CA2155323A1 (en) Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
DE60015390D1 (de) Antidiabetische thiazolidindione und ihre herstellung
DK0902018T3 (da) 2-(arylpheny)amino-imidazolinderivater
AU1289600A (en) Process for racemization
ATE464043T1 (de) Pharmazeutische zusammensetzung enthaltend l- arginin
CA2300289A1 (en) A pharmaceutical composition active in reducing production of mcp-1 protein
WO2004094398A3 (en) Synthesis of 2-hydroxy-n,n-dimethyl-3-[[2-[1(r)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]benzamide
GR3017348T3 (en) Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same.
MXPA04002640A (es) Esteres de analogos de 3-desoxi-vitamina d3.
BR0112876A (pt) Processo para preparação de discodermolida e seus análogos
DK0952157T3 (da) 9a, 11b-dehydroderivater af 9-oxim-3-keto-6-0-methylerythromycin
DE60212086D1 (de) Stabile kristalle von pyrrolverbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1270575

Country of ref document: EP